TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Should Cannabis Investors Worry About a Legalization Delay?
Investing
Could Conservative Senators Trigger a Marijuana Stock Meltdown?
Investing
At 135-Times Sales, Cannabis Valuations Make No Sense Whatsoever
Investing
10 Growth Stocks to Put on Your Shopping List for 2018
Investing
Canopy Growth Corp. Secures a Supply Deal With Another Province
Investing
This Is the Number 1 Cannabis Stock to Own for the Next Decade
Investing
Canopy Growth Corp. vs. Aphria Inc.: Which Marijuana Stock Offers Better Value?
Investing
Making a List and Checking it Twice — for Investors
Investing
Bitcoin Makes Marijuana Stocks Look Like Safe Investments
Metals and Mining Stocks
Of Bitcoin, Bubbles, and Investor Psychology
Investing
Buy Now: 3 Reasons Marijuana Stocks Are Going to Soar in 2018